Jiangxi Rimag Group (SEHK:2522) - Stock Price, News & Analysis

2522 Stock Overview

Operates medical imaging centers in China.

2522 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	4/6
Financial Health	5/6
Dividends	0/6

Rewards

Earnings grew by 12101.9% over the past year

Risk Analysis

Shares are highly illiquid

Jiangxi Rimag Group Co., Ltd. Competitors

Yunkang Group

SEHK:2325

HK$6.5b

New Horizon Health

SEHK:6606

HK$6.3b

Adicon Holdings

SEHK:9860

HK$6.2b

Jinxin Fertility Group

SEHK:1951

HK$8.3b

Price History & Performance

Summary of all time highs, changes and price drops for Jiangxi Rimag Group
Historical stock prices
Current Share Price	HK$20.20
52 Week High	HK$22.80
52 Week Low	HK$13.50
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	34.67%

Recent updates

Shareholder Returns

	2522	HK Healthcare	HK Market
7D	31.9%	-4.3%	-2.3%
1Y	n/a	-24.3%	-3.6%

Return vs Industry: Insufficient data to determine how 2522 performed against the Hong Kong Healthcare industry.

Return vs Market: Insufficient data to determine how 2522 performed against the Hong Kong Market.

Price Volatility

Is 2522's price volatile compared to industry and market?
2522 volatility
2522 Average Weekly Movement	n/a
Healthcare Industry Average Movement	5.8%
Market Average Movement	7.2%
10% most volatile stocks in HK Market	15.2%
10% least volatile stocks in HK Market	3.7%

Stable Share Price: 2522's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine 2522's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2014	1,006	Zhaoyang Chen	www.rimag.com.cn

Jiangxi Rimag Group Co., Ltd. operates medical imaging centers in China. The company offers imaging examination and diagnostic service, such as MRI, CT, PET, X-ray, ultrasound, and mammography to patients and other healthcare consumers; imaging solution services; and Rimag Cloud services, including cloud storage and cloud film module services, cloud radiology information system services, cloud Picture Archive and Communication System services, and imaging AI integration platform modules and operational management modules. It also operates and manages medical imaging platform that provides diversified imaging services; research and development center; and sells medical equipment and consumables.

Jiangxi Rimag Group Co., Ltd. Fundamentals Summary

How do Jiangxi Rimag Group's earnings and revenue compare to its market cap?
2522 fundamental statistics
Market cap	HK$6.85b
Earnings (TTM)	HK$47.80m
Revenue (TTM)	HK$999.70m

150.6x

P/E Ratio

7.2x

P/S Ratio

Is 2522 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2522 income statement (TTM)
Revenue	CN¥928.91m
Cost of Revenue	CN¥596.32m
Gross Profit	CN¥332.60m
Other Expenses	CN¥288.18m
Earnings	CN¥44.42m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	0.12
Gross Margin	35.80%
Net Profit Margin	4.78%
Debt/Equity Ratio	15.8%

How did 2522 perform over the long term?

See historical performance and comparison

Jiangxi Rimag Group SEHK:2522 Stock Report